方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| COVID-19感染恐惧量表× | 新冠焦虑量表× | |
|---|---|---|
| 领域 | 公共卫生 | 公共卫生 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份 | 2020 | 2020 |
| 提出者≠ | Ahorsu et al. | Lipp et al. |
| 类型 | Self-report | Self-report |
| 开创性文献≠ | Ahorsu, D. K., Lin, C. Y., Imani, V., Saffari, M., Griffiths, M. D., & Pakpour, A. H. (2020). The Fear of COVID-19 Scale: Development, initial validation, and reliability testing. International Journal of Mental Health and Addiction, 20(3), 1146–1159. DOI ↗ | Lipp, A., Fazio, S., & Cohen, S. (2020). COVID-19 anxiety in the United States. International Journal of Mental Health and Addiction, 20(3), 1234–1248. link ↗ |
| 别名≠ | FCV-19S, Fear of COVID-19 Scale | CAS |
| 相关 | 3 | 3 |
| 摘要≠ | The Fear of COVID-19 Scale (FCV-19S) is a 7-item, self-report instrument assessing fear of COVID-19 infection across cognitive, emotional, and physiological domains. Developed by Ahorsu and colleagues in 2020, it measures threat perception, anxiety symptoms triggered by disease-related triggers, and avoidance behaviors. The FCV-19S has been translated into over 40 languages and validated across diverse populations, making it the most widely used pandemic-specific fear measure globally. | The COVID-19 Anxiety Scale (CAS) is a brief, self-administered instrument designed to assess anxiety symptoms specifically related to the COVID-19 pandemic. Developed by Lipp and colleagues in 2020, it captures worry about infection, social isolation, and pandemic-related uncertainties. The scale is widely used in epidemiological surveys and clinical research to identify individuals experiencing pandemic-related anxiety requiring intervention. |
| ScholarGate数据集 ↗ |
|
|